US tariffs hit Indian pharma: A warning sign for exports
The United States has imposed a 100% tariff on imported branded and patented drugs, a move that directly targets foreign manufacturers. While Indian generic drugs remain exempt for now, the policy raises serious concerns for India’s pharmaceutical industry and its future in the US market.
You may also like
Recent Posts
- Sahayatha: A smart wheelchair restoring dignity through innovation
Sruthi developed Sahayatha, a revolutionary wheelchair that empowers persons with disabilities to live independently. - Kasol – The Mini Israel of IndiaBeyond culture, Kasol’s mesmerising landscape captivates every visitor.
- India’s crackdown on dark patterns in e-commerceIndia’s crackdown on dark patterns marks a major step toward responsible e-commerce growth.
WeRIndia – A News Aggregator
Visit werindia.com for all types of National | Business | World | Politics | Entertainment | Health related news and much more..
Opinion Polls
Loading ...
Leave a Reply